Alterity Therapeutics (ASX:ATH) - Webinar Presentation

09/08/2024 14:30:00

This video is not supported on your device. Click here for the original version.


Dr David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.